Post-surgical, residual enhancing tumor volume is prognostic for overall survival in newly diagnosed glioblastoma: Evidence from 1,458 patients pooled from international trials, single institution databases, and multicenter consortiums Meeting Abstract

   

Authors:	Ellingson, B.; Abrey, L.; Nelson, S.; Garcia, J.; Chinot, O.; Saran, F.; Nishikawa, R.; Henriksson, R.; Mason, W.; Wick, W.; Butowski, N.; Ligon, K.; Gerstner, E.; Colman, H.; de Groot, J.; Chang, S.; Mellinghoff, I. K.; Young, R. J.; Colen, R.; Taylor, J.; Arrillaga-Romany, I.; Huang, R.; Pope, W.; Reardon, D.; Batchelor, T.; Wen, P.; Prados, M.; Cloughesy, T. F.
Abstract Title:	Post-surgical, residual enhancing tumor volume is prognostic for overall survival in newly diagnosed glioblastoma: Evidence from 1,458 patients pooled from international trials, single institution databases, and multicenter consortiums
Meeting Title:	22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	19
Issue:	Suppl. 6
Meeting Dates:	2017 Nov 16-19
Meeting Location:	San Francisco, CA
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2017-11-01
Start Page:	vi154
Language:	English
ACCESSION:	WOS:000415152502237
PROVIDER:	wos
DOI:	10.1093/neuonc/nox168.627
PMCID:	PMC5692758
Notes:	Meeting Abstract: NIMG-53 -- Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS -- NOV 15-19, 2017 -- San Francisco, CA -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/120300